News
Results 46 to 60 of 73.
Search
-
WRVS’ £1m gift to Sheffield Teaching Hospitals
Patients at Sheffield Teaching Hospitals will benefit from a generous £1million gift from WRVS, presented by volunteers and the Rt. Hon. David Blunkett MP at a ceremony on 7 January.
Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health -
Breakthrough in drug trial offers hope for heart attack patients
New findings from a major drug trial have brought experts a step closer to developing a drug which could prevent thousands of British deaths from heart attacks.
Categorised under: University of Sheffield, Cardiovascular Science, Research and Medicine-Dentistry-Health -
Commonly used blood pressure drugs 'increase cancer risk'
Researchers found significantly increased rates of all cancers among patients taking the drugs.
The class of drugs, called Angiotensin-receptor blockers (ARBs), are widely used to treat high blood pressure as well as heart failure and kidney damage caused by diabetes.
Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health -
Risk of blood clots after surgery is higher than thought
The risk of suffering a potentially fatal blood clot after surgery is higher than previously thought - and the risk remains high for up to three months, a new study has found.
Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health -
Taking part in research helps heart attack victim bounce back
The MRC ILA-HEART study aims to determine the effect of the interleukin-1 receptor antagonist (IL-1 ra Anakinra on the inflammatory processes triggered by non-ST elevation myocardial infarction
Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health -
Sheffield academic is UK lead for worldwide trial
An academic from the University of Sheffield has led UK investigations into a new drug that could prevent thousands of British deaths from heart attacks.
Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health -
Sheffield academic scoops prestigious international award
An academic from the University of Sheffield has received a prestigious World Federation of Neurological Societies (WFNS) Young Neurosurgeon Award, for his outstanding contribution to the field of medical research.
Categorised under: University of Sheffield, Cardiovascular Science and Medicine-Dentistry-Health -
New drug could reduce the chances of a second heart attack
A new drug reduced the risk of dying from a heart attack or other cardiac problem by one fifth compared to the current gold standard drug.
The results of a study were presented at the European Society of Cardiology in Barcelona, Spain and were published in the New England Journal of Medicine
Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health -
Migraines 'raise pregnancy risk'
Migraines substantially raise the risk of a stroke during pregnancy, a US study suggests.
Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health -
Women with faster heart beat could have a higher cardiac risk
The speed of a woman's heart beat could predict how likely she is to suffer a heart attack, researchers say.
Categorised under: University of Sheffield, Cardiovascular Science, Research and Medicine-Dentistry-Health -
Gene Variation May Lead to Early Cardiovascular Disease
Researchers at Duke University Medical Center have identified a variation in a particular gene that increases a person’s susceptibility to early coronary artery disease. For years, scientists have known that the devastating, early-onset form of the disease was inherited, but knew little about the gene or genes responsible.
Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health -
Clopidogrel Less Effective in Young MI Patients with Gene Variant
For the small percentage of MI patients younger than 45 who are homozygous for a certain gene variant, clopidogrel (Plavix) may be significantly less effective in secondary prevention.
Categorised under: University of Sheffield, Cardiovascular Science, Patients, Research and Medicine-Dentistry-Health -
Dark chocolate diet reduces risk of stroke and heart disease, study suggests
Eating dark chocolate every day could help guard against heart disease and stroke, new research has suggested.
Categorised under: University of Sheffield, Cardiovascular Science, Research and Medicine-Dentistry-Health -
Philips Led 'euHeart' Project Targets Highly Personalised Diagnosis And Treatment Of Cardiovascular
Royal Philips Electronics announced that it will lead a new European Union (EU) funded research project called 'euHeart', which is aimed at improving the diagnosis, therapy planning and treatment of cardiovascular disease - one of the biggest causes of mortality in the western world.
Categorised under: University of Sheffield, Cardiovascular Science, Research and Medicine-Dentistry-Health -
Hidden haemophilia cuts heart risk
People who carry the haemophilia gene, but who do not have the illness may enjoy protection from heart disease, say doctors.
Categorised under: University of Sheffield, Cardiovascular Science, Research and Medicine-Dentistry-Health